Oncology trials, clearly dominant in the global clinical trials landscape, stand out due to many complexities. This includes: disease heterogeneity, elaborate study designs, specific patient population, and rapid evolution in treatment standards, which lead to rapidly-changing guidelines.

This e-book will guide you through current trends and considerations in cancer drug development, whilst examining the practicalities and benefits of conducting clinical research in the European region.

This guide will focus on the following topics:

• Current Oncology Trends in Clinical Trials
• Why Choose Europe for Cancer Drug Development?
• Knowing the Key Players in Clinical Research in the EU
• Challenges to Consider
• How to Mitigate Possible Risks